secwatch.observer — SEC 8-K summary
======================================

Issuer:     Instil Bio, Inc. (TIL)
CIK:        0001789769
Form:       8-K
Filed at:   2024-09-06T23:59:59+00:00
Accession:  0001628280-24-039726
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 2.05
LLM model:  deepseek-v4-flash:cloud@v2

Instil Bio to close remaining UK operations, cut workforce, incur up to $5.5M in restructuring costs
--------------------------------------------------------------------------------

- Board approved restructuring plan to close Manchester, UK operations and eliminate remaining UK workforce.
- Estimated aggregate restructuring costs up to $5.5M, including asset impairment ($2.2M), severance ($2.0M), and contract termination ($1.3M).
- Workforce reduction expected to be substantially complete by end of 2024.
- Charges are subject to assumptions; additional costs may arise not currently contemplated.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1789769/000162828024039726/0001628280-24-039726-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1789769/000162828024039726/til-20240901.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-039726

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer